Fig. 4From: Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect Vitreous body vessels regressed in mice. The vessels were stained with isolectin B4 alone, FITC alone, and isolectin B4 combined with FITC-dextran by retro-orbital (RO) injection. a: Fluorescence of the vitreous body vessels filled with FITC-dextran (red arrow) or stained with isolectin B4 (yellow arrow) from the P1 samples; b: On P3, the FITC-dextran fluorescence of the vitreous body vessels was slightly reduced (red arrow); c: On P5, the FITC-dextran fluorescence of specific vitreous body vessels was considerably reduced (red arrow); d: The vitreous body vessels (yellow arrow) of OIR-P17 mice could not be fully injected with FITC-dextran. n = 20 from 20 mice. Original magnification, 50×Back to article page